The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors
- 31 May 1995
- journal article
- clinical trial
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 35 (2), 100-106
- https://doi.org/10.1016/0167-8140(95)01539-s
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Hyperfractionated compared with conventional radiotherapy in oropharyngeal carcinoma: an EORTC randomized trialEuropean Journal of Cancer and Clinical Oncology, 1990
- The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: An interim reportInternational Journal of Radiation Oncology*Biology*Physics, 1990
- A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: Clinical and treatment parameters as prognostic factorsRadiotherapy and Oncology, 1989
- Prognostic factors for loco/regional control and metastasis and the impact on survivalInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Radiation therapy alone or in combination with surgery in head and neck cancerCancer, 1985
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958